Novartis
NVS
NVS
1,372 hedge funds and large institutions have $17.2B invested in Novartis in 2025 Q3 according to their latest regulatory filings, with 113 funds opening new positions, 468 increasing their positions, 474 reducing their positions, and 72 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
1% less repeat investments, than reductions
Existing positions increased: 468 | Existing positions reduced: 474
34% less call options, than puts
Call options by funds: $261M | Put options by funds: $398M
35% less funds holding in top 10
Funds holding in top 10: 17 → 11 (-6)
Holders
1,372
Holding in Top 10
11
Calls
$261M
Puts
$398M
Top Buyers
| 1 | +$282M | |
| 2 | +$92.4M | |
| 3 | +$61.6M | |
| 4 |
Goldman Sachs
New York
|
+$52.3M |
| 5 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
+$40.6M |
Top Sellers
| 1 | -$141M | |
| 2 | -$136M | |
| 3 | -$107M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$90.4M |
| 5 |
Renaissance Technologies
New York
|
-$53.9M |
